Skip to main content

Universal pattern of RpoB gene mutations among multidrug-resistant isolates of Mycobacterium tuberculosis complex from Africa

Buy Article:

$34.78 + tax (Refund Policy)

Setting: Multidrug-resistant tuberculosis (MDR-TB) presents an increasing burden in Southern Africa. Rapid diagnostic tests for drug resistance to rifampicin have been developed based on mutation analysis of the RpoB gene. However, geographic differences of underlying mutations have recently been suggested.

Objective: Drug-resistant strains of Mycobacterium tuberculosis complex from Africa were analysed for geographic differences in frequency and location of RpoB mutations.

Design: A random sample of rifampicin-resistant strains was collected from 87 patients with pulmonary MDR-TB treated in 12 hospitals from six different regions of South Africa. In addition, 18 isolates of M. tuberculosis complex from Namibia, Sierra Leone, and Uganda, including 13 isolates of M. africanum, were analyzed. Point mutations were detected by direct sequence analysis of the RpoB gene.

Results: Missense mutations were identified for 91 isolates (87%). Double mutations were present in eight (8%) MDR-TB isolates, two of which carried one mutation outside a previously described diagnostic region. We found no geographic differences regarding the frequency and pattern of single RpoB gene mutations.

Conclusion: Our results confirm that molecular genetic analysis of rifampicin resistance based on a core region within the RpoB gene is universally applicable to strains of M. tuberculosis complex from different geographic regions.

Keywords: M. africanum; M. tuberculosis; MDR-TB; rifampicin resistance; rpoB gene

Document Type: Regular Paper

Affiliations: 1: Department of General Pediatrics, Children's Hospital, University of Heidelberg, Heidelberg, Germany 2: Tuberculosis Research Institute, Medical Research Council, Pretoria, South Africa 3: Mycobacteriology Laboratory, Armauer-Hansen Institute, German Leprosy Relief Association, WŸrzburg, Germany

Publication date: 01 July 1999

More about this publication?
  • The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.

    The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.

  • Editorial Board
  • Information for Authors
  • Subscribe to this Title
  • International Journal of Tuberculosis and Lung Disease
  • Public Health Action
  • Ingenta Connect is not responsible for the content or availability of external websites
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content